FdaApplication
ANDA 220709
Identifiers
- fda_app_no: ANDA220709
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA INC |
| application_type | ANDA |
| approval_date | 2026-05-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEFLAZACORT | DEFLAZACORT | 22.75MG/ML | SUSPENSION;ORAL |
1 product